Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia

Alzheimer's and Dementia

Volumn 2, Issue 1, 2006, Pages 36-42

  Jagust, William ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Dementia; Glucose metabolism; Imaging; Magnetic resonance imaging; Positron emission tomography

Indexed keywords

AMYLOID PROTEIN; FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; BRAIN FUNCTION; BRAIN METABOLISM; COGNITIVE DEFECT; DATA ANALYSIS; DEMENTIA; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; GENETIC RISK; HUMAN; MEDICAL TECHNOLOGY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 33144484369     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2005.11.002     Document Type: Review

References (46)

1. D.S. Knopman S.T. DeKosky J.L. Cummings H. Chui J. Corey-Bloom N. Relkin et al. Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 2001 1143-1153
2. Y. Hirata H. Matsuda K. Nemoto T. Ohnishi K. Hirao F. Yamashita et al. Voxel-based morphometry to discriminate early Alzheimer's disease from controls Neurosci Lett 382 2005 269-274
3. P. Scheltens D. Leys F. Barkhof D. Huglo H.C. Weinstein P. Vermersch et al. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: Diagnostic value and neuropsychological correlates J Neurol Neurosurg Psychiatr 55 1992 967-972
4. M.P. Laakso H. Soininen K. Partanen M. Lehtovirta M. Hallikainen T. Hänninen et al. MRI of the hippocampus in Alzheimer's disease Sensitivity, specificity, and analysis of the incorrectly classified subjects Neurobiol Aging 19 1998 23-31
5. M.P. Laakso K. Partanen P. Riekkinen M. Lehtovirta E.-L. Helkala M. Hallikainen et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia an MRI study Neurology 46 1996 678-681
6. G.B. Frisoni M.P. Laakso A. Beltramello C. Geroldi A. Bianchetti H. Soininen et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease Neurology 52 1999 91-100
7. Z. Nagy N.J. Hindley H. Braak E. Braak D.M. Yilmazer-Hanke C. Schultz et al. Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': A prospective study Dement Geriatr Cogn Disord 10 1999 109-114
8. K.M. Gosche J.A. Mortimer C.D. Smith W.R. Markesbery D.A. Snowdon Hippocampal volume as an index of Alzheimer neuropathology: Findings from the Nun Study Neurology 58 2002 1476-1482
9. C.R. Jack D.W. Dickson J.E. Parisi Y.C. Xu R.H. Cha P.C. O'Brien Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia Neurology 58 2002 750-757
10. A.F. Fotenos A.Z. Snyder L.E. Girton J.C. Morris R.L. Buckner Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD Neurology 64 2005 1032-1039
11. N.C. Fox P.A. Freeborough M.N. Rossor Visualization and quantification of rates of atrophy in Alzheimer's disease Lancet 348 1996 94-97
12. N.C. Fox E.K. Warrington M.N. Rossor Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease Lancet 353 1999 2125
13. L.C. Silbert J.F. Quinn M.M. Moore E. Corbridge M.J. Ball G. Murdoch et al. Changes in premorbid brain volume predict Alzheimer's disease pathology Neurology 61 2003 487-492
14. C.R. Jack R.C. Petersen Y.C. Xu P.C. O'Brien G.E. Smith R.J. Ivnik et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment Neurology 52 1999 1397-1403
15. P.J. Visser F.R. Verhey P.A. Hofman P. Scheltens J. Jolles Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment J Neurol Neurosurg Psychiatry 72 2002 491-497
16. C.R. Jack M.M. Shiung J.L. Gunter P.C. O'Brien S.D. Weigand D.S. Knopman et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD Neurology 62 2004 591-600
17. C.R. Jack Jr M.M. Shiung S.D. Weigand P.C. O'Brien J.L. Gunter B.F. Boeve et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI Neurology 65 2005 1227-1231
18. L. deToledo-Morrell T.R. Stoub M. Bulgakova R.S. Wilson D.A. Bennett S. Leurgans et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD Neurobiol Aging 25 2004 1197-1203
19. C. DeCarli D. Mungas D. Harvey B. Reed M. Weiner H. Chui et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia Neurology 63 2004 220-227
20. S. Minoshima K.A. Frey R.A. Koeppe N.L. Foster D.E. Kuhl A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET J Nucl Med 36 1995 1238-1248
21. S. Minoshima B. Giordani S. Berent K.A. Frey N.L. Foster D.E. Kuhl Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Ann Neurol 42 1997 85-94
22. K. Herholz PET studies in dementia Ann Nucl Med 17 2003 79-89
23. C. Holmes N. Cairns P. Lantos A. Mann Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies Br J Psychiatry 174 1999 45-50
24. A. Lim D. Tsuang W. Kukull D. Nochlin J. Leverenz W. McCormick et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series J Am Geriatr Soc 47 1999 564-569
25. J.M. Hoffman K.A. Welsh-Bohmer M. Hanson B. Crain C. Hulette N. Earl et al. FDG PET imaging in patients with pathologically verified dementia J Nucl Med 41 2000 1920-1928
26. D.H. Silverman G.W. Small C.Y. Chang C.S. Lu M.A. Kung De Aburto W. Chen et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome JAMA 286 2001 2120-2127
27. W. Jagust R. Thisted M.D. Devous Sr R. Van Heertum H. Mayberg K. Jobst et al. SPECT perfusion imaging in the diagnosis of Alzheimer's disease: A clinical-pathologic study Neurology 56 2001 950-956
28. R.L. Albin S. Minoshima C.J. D'Amato K.A. Frey D.A. Kuhl A.A.F. Sima Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease Neurolgy 47 1996 462-466
29. T. Imamura K. Ishii M. Sasaki H. Kitagaki S. Yamaji N. Hirono Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: A comparative study using positron emission tomography Neurosci Lett 235 1997 49-52
30. S. Minoshima N.L. Foster A.A. Sima K.A. Frey R.L. Albin D.E. Kuhl Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation Ann Neurol 50 2001 358-365
31. K. Ishii S. Sakamoto M. Sasaki H. Kitagaki S. Yamaji M. Hashimoto et al. Cerebral glucose metabolism in patients with frontotemporal dementia J Nucl Med 39 1998 1875-1878
32. P. Santens J. De Bleecker P. Goethals K. Strijckmans I. Lemahieu G. Slegers et al. Differential regional cerebral uptake of (18)F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis Eur Neurol 45 2001 19-27
33. E.M. Reiman R.J. Caselli L.S. Yun K. Chen D. Bandy S. Minoshima et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the e4 allele for apolipoprotein E N Engl J Med 334 1996 752-758
34. E.M. Reiman K. Chen G.E. Alexander R.J. Caselli D. Bandy D. Osborne et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia Proc Natl Acad Sci U S A 101 2004 284-289
35. A.M. Kennedy R.S.J. Frackowiak S.K. Newman P.M. Bloomfield J. Seaward P. Roques et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease Neurosci Lett 186 1995 17-20
36. E. Arnaiz V. Jelic O. Almkvist L.O. Wahlund B. Winblad S. Valind et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment Neuroreport 12 2001 851-855
37. G. Chetelat B. Desgranges V. De La Sayette F. Viader F. Eustache J.C. Baron Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 60 2003 1374-1377
38. M.J. de Leon A. Convit O.T. Wolf C.Y. Tarshish S. DeSanti H. Rusinek et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET) Proc Natl Acad Sci U S A 98 2001 10966-10971
39. B.C. Dickerson D.H. Salat J.F. Bates M. Atiya R.J. Killiany D.N. Greve et al. Medial temporal lobe function and structure in mild cognitive impairment Ann Neurol 56 2004 27-35
40. S.A. Small G.M. Perera R. DeLaPaz R. Mayeux Y. Stern Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease Ann Neurol 45 1999 466-472
41. C.D. Smith A.H. Andersen R.J. Kryscio F.A. Schmitt M.S. Kindy L.X. Blonder et al. Altered brain activation in cognitively intact individuals at high risk for Alzheimer's disease Neurology 53 1999 1391-1396
42. K. Shoghi-Jadid G.W. Small E.D. Agdeppa V. Kepe L.M. Ercoli P. Siddarth et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am J Geriatr Psychiatry 10 2002 24-35
43. W.E. Klunk H. Engler A. Nordberg Y. Wang G. Blomqvist D.P. Holt et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann Neurol 55 2004 306-319
44. N.P. Verhoeff A.A. Wilson S. Takeshita L. Trop D. Hussey K. Singh et al. In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET Am J Geriatr Psychiatry 12 2004 584-595
45. D.G. Davis F.A. Schmitt D.R. Wekstein W.R. Markesbery Alzheimer neuropathologic alterations in aged cognitively normal subjects J Neuropathol Exp Neurol 58 1999 376-388
46. S.G. Mueller M.W. Weiner L.J. Thal R.C. Petersen C.J. Jack W. Jagust Ways toward an early diagnosis in Alzheimer's disease. The Alzheimer's Disease Neuroimaging Initiative Alzheimer's and Dementia 1 2005 55-66